ADMA DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA
Rosen Law Firm issued a shareholder-solicitation notice regarding ADMA Biologics; no new disclosure from the company itself. The firm reminds investors of an August 10, 2026 deadline to move for lead plaintiff status in a class action alleging undisclosed related party transactions and channel stuffing.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.